(Q48420914)

11 February 2018

title

Evaluation of 75Br-labelled butyrophenone neuroleptics for imaging cerebral dopaminergic receptor areas using positron emission tomography. (English)

1 reference

11 February 2018

1 reference

6

W D Heiss

1 reference

11 February 2018

author name string

S M Moerlein

1

1 reference

11 February 2018

P Laufer

2

1 reference

11 February 2018

G Stöcklin

3

1 reference

11 February 2018

G Pawlik

4

1 reference

11 February 2018

K Wienhard

5

1 reference

11 February 2018

publication date

1 January 1986

1 reference

11 February 2018

European Journal of Nuclear Medicine and Molecular Imaging

published in

1 reference

11 February 2018

volume

12

1 reference

11 February 2018

issue

4

1 reference

11 February 2018

page(s)

211-216

1 reference

11 February 2018

describes a project that uses

positron emission tomography

1 reference

https://scigraph.springernature.com/pub.10.1007/bf00256924

inferred from title

exact match

0 references

cites work

Relationship of neuroleptic drug effects at brain dopamine, serotonin, alpha-adrenergic, and histamine receptors to clinical potency

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF00256924

Alterations in dopaminergic receptors in Huntington's disease

21 January 2018

1 reference

12 December 2020

Resolution of dopamine and serotonin receptor components of [3H]spiperone binding to rat brain regions

1 reference

12 December 2020

Comparison of three 18F-labeled butyrophenone neuroleptic drugs in the baboon using positron emission tomography.

1 reference

12 December 2020

The use of radiobrominated p-bromospiroperidol for gamma-ray imaging of dopamine receptors.

1 reference

12 December 2020

Syntheses and specific activity determinations of no-carrier-added (NCA) F-18-labeled butyrophenone neuroleptics--benperidol, haloperidol, spiroperidol, and pipamperone.

1 reference

12 December 2020

Increased dopamine-receptor sensitivity in schizophrenia

1 reference

12 December 2020

Effect of lipophilicity on the in vivo localization of radiolabelled spiperone analogues.

1 reference

12 December 2020

Imaging dopamine receptors in the human brain by positron tomography.

1 reference

12 December 2020

A comparative study of [3 H] haloperidol and [3 H] spiroperidol binding to receptors on rat cerebral membranes

1 reference

12 December 2020

Carrier-added and no-carrier-added syntheses of [18F]spiroperidol and [18F]haloperidol

1 reference

12 December 2020

Synthesis of high specific activity [75Br]- and [77Br]bromperidol and tissue distribution studies in the rat.

1 reference

12 December 2020

Preliminary studies with [18F]haloperidol: a radioligand for in vivo studies of the dopamine receptors

1 reference

12 December 2020

Evidence for loss of brain [3H]spiroperidil and [3H]ADTN binding sites in rabbit brain with aging

1 reference

12 December 2020

A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography

1 reference

12 December 2020

Neuropathological investigation of 28 brains from patients with dyskinesia

1 reference

12 December 2020

Specific in vivo binding of neuroleptic drugs in rat brain

1 reference

12 December 2020

[18F]-N-Methylspiroperidol: the radioligand of choice for PETT studies of the dopamine receptor in human brain.

1 reference

12 December 2020

Spiperone: a ligand of choice for neuroleptic receptors. 1. Kinetics and characteristics of in vitro binding

1 reference

12 December 2020

Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain

1 reference

12 December 2020

Bimodal Distribution of Dopamine Receptor Densities in Brains of Schizophrenics

1 reference

12 December 2020

Binding of 3H-neuroleptics and 3H-apomorphine in schizophrenic brains

1 reference

12 December 2020

Dopamine receptors displayed in living human brain with 77Br-p-bromospiperone.

1 reference

12 December 2020

Comparison in animal models of 18F-spiroperidol and 18F-haloperidol: potential agents for imaging the dopamine receptor.

1 reference

12 December 2020

Neurotransmitter receptor alterations in Parkinson's disease

1 reference

12 December 2020

Assessment of dopamine receptor densities in the human brain with carbon-11-labeled N-methylspiperone

1 reference

12 December 2020

Dopamine receptor binding in vivo: The feasibility of autoradiographic studies

1 reference

12 December 2020

Regional studies of catecholamines in the rat brain. I. The disposition of [3H]norepinephrine, [3H]dopamine and [3H]dopa in various regions of the brain

1 reference

12 December 2020

Inhibition of calcium-dependent regulator-stimulated phosphodiesterase activity by neuroleptic drugs is unrelated to their clinical efficacy

1 reference

12 December 2020

Mapping brain neuroleptic receptors in the live baboon.

1 reference

12 December 2020

Synthesis and biological evaluation of p-bromospiperone as potential neuroleptic drug

1 reference

12 December 2020

76Br-bromospiroperidol: A new tool for quantitative in-vivo imaging of neuroleptic receptors

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00256924

1 reference

11 February 2018

1 reference

11 February 2018